FOSUN INTL(00656),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00656 FOSUN INTL

Closing Auction 04-15 16:02:25

4.030

-0.040

-0.98%

High4.090	Low4.010	Vol9.45M
Open4.010	D1 Closing4.070	Amplitude1.97%
Mkt Cap32.97B	Tradable Cap32.97B	Total Shares8.18B
T/O38.39M	T/O Rate0.12%	Tradable Shares8.18B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00656","market":"HK","secType":"STK","nameCN":"FOSUN INTL","latestPrice":4.03,"timestamp":1776240092693,"preClose":4.07,"halted":0,"volume":9449012,"delay":0,"changeRate":-0.009828009828009836,"floatShares":8180000000,"shares":8180000000,"eps":-3.3111367785918575,"marketStatus":"Closing Auction","change":-0.04,"latestTime":"04-15 16:02:25","open":4.01,"high":4.09,"low":4.01,"amount":38389756,"amplitude":0.019656,"askPrice":4.03,"askSize":239500,"bidPrice":4.03,"bidSize":347000,"shortable":3,"etf":0,"ttmEps":-3.3111367785918575,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776240600000},"marketStatusCode":4,"adr":0,"listingDate":1184515200000,"exchange":"SEHK","adjPreClose":4.07,"dividendRate":0.004988,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":0.600291,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00656","defaultTab":"news","newsList":[{"id":"1162297042","title":"FOSUN INTL Repurchases 1.2 Million Shares for HK$4.87 Million on April 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1162297042","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162297042?lang=en_us&edition=fundamental","pubTime":"2026-04-14 18:37","pubTimestamp":1776163048,"startTime":"0","endTime":"0","summary":"FOSUN INTL (00656) announced that on April 14, 2026, the company repurchased 1.2 million of its shares at a total cost of HK$4.87 million.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627141799","title":"Fosun files HKEX next-day return disclosing share buyback at HKD 4.05 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2627141799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627141799?lang=en_us&edition=fundamental","pubTime":"2026-04-14 18:33","pubTimestamp":1776162827,"startTime":"0","endTime":"0","summary":"Fosun International repurchased 1,200,000 shares on April 14, 2026.Buyback price ranged from HKD 3.98 to HKD 4.1 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL5lkFDQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106797409","title":"Fuzhou Life Insurance Makes Major Real Estate Acquisition with Purchase of Fosun International Financial Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797409","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106797409?lang=en_us&edition=fundamental","pubTime":"2026-04-14 18:21","pubTimestamp":1776162082,"startTime":"0","endTime":"0","summary":"Jinan state-owned assets have reshaped the destiny of Fuzhou Life Insurance. As a newly established institution founded in 2025, Fuzhou Life Insurance has low market recognition. Compounded by the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627414768","title":"Fosun Kairos wins China nod for Phase I/II trial of FKC289 CAR-T injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2627414768","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627414768?lang=en_us&edition=fundamental","pubTime":"2026-04-14 17:59","pubTimestamp":1776160770,"startTime":"0","endTime":"0","summary":"Fosun Kairos, unit of Fosun Pharma, secured China regulator clearance for Phase I/II clinical trials of FKC289 injection.Trials target relapsed or refractory primary light chain amyloidosis, relapsed or refractory membranous nephropathy.FKC289 is dual-target CAR-T therapy aimed at BCMA, CD19.Fosun Pharma R&D spending on FKC289 totaled about RMB 59 million as of March 2026.Fosun Pharma said no therapies using same molecular mechanism have been marketed globally as of April 14.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 14, 2026, and is sol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDLbGc62m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230","BK0183","BK0188","BK0187","BK0175","BK0060","600196","BK0096","BK0239","BK0012","BK0196","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627194544","title":"Shanghai Henlius says NMPA clears HLX05-N cetuximab biosimilar Phase 1 trial application","url":"https://stock-news.laohu8.com/highlight/detail?id=2627194544","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627194544?lang=en_us&edition=fundamental","pubTime":"2026-04-14 17:01","pubTimestamp":1776157281,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech received China NMPA clearance for phase 1 clinical trial application of HLX05-N, a cetuximab biosimilar, in metastatic colorectal cancer.Company plans an international multicenter phase 1 study once conditions are met.Global cetuximab biosimilar sales totaled about USD 1.7 billion in 2025, according to IQVIA MIDAS.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL8Yml22:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000306685.HKD","BK1161","BK1230","00656","02696","HK0000165453.HKD","HK0000320223.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113013280","title":"FOSUN INTL Chairman Vows Continued Commitment to Hainan Free Trade Port Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1113013280","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113013280?lang=en_us&edition=fundamental","pubTime":"2026-04-14 12:22","pubTimestamp":1776140521,"startTime":"0","endTime":"0","summary":"On April 14, the 2026 Hainan Free Trade Port Global Industrial Investment Promotion Conference was held in Haikou. Co-hosted by the Hainan Provincial People's Government and the Ministry of Commerce...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626951711","title":"Fosun Pharma unit Yaopharma wins China approval for flurbiprofen axetil injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2626951711","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626951711?lang=en_us&edition=fundamental","pubTime":"2026-04-10 17:37","pubTimestamp":1775813874,"startTime":"0","endTime":"0","summary":"Fosun Pharma unit Yaopharma won China marketing clearance for flurbiprofen axetil injection for post-surgical pain and cancer-related analgesia.Approval covers 5 ml:50 mg strength under chemicals Category 3.Fosun Pharma disclosed cumulative R&D spending of about RMB 34 million as of March 2026.IQVIA CHPA data cited 2025 China sales for flurbiprofen axetil injection at about RMB 1.2 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL548Bdv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0239","BK0175","LU1201861249.SGD","BK0196","BK0183","BK4121","LU0130518102.USD","LU0528227936.USD","LU0648000940.SGD","LU1261432733.SGD","LU0648001328.SGD","LU0882574055.USD","IQV","LU0477156797.USD","BK4588","BK0028","BK0187","LU1791710400.SGD","BK0060","00656","BK0188","BK4585","LU0980610538.SGD","600196","LU1989764664.SGD","LU1201861165.SGD","LU0198837287.USD","LU0130103400.USD","BK0096","LU0130517989.USD","LU1989764748.USD","LU1791710582.SGD","BK1230","BK4530","LU0477156953.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626931221","title":"Fosun Pharma board to review first-quarter results, approve release","url":"https://stock-news.laohu8.com/highlight/detail?id=2626931221","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626931221?lang=en_us&edition=fundamental","pubTime":"2026-04-10 17:11","pubTimestamp":1775812288,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical board meeting scheduled for April 28, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8FKbFx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK1230","BK0239","00656","BK0183","BK0012","BK0187","BK0188","BK0096","600196","BK0028","BK0196","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626719827","title":"Shanghai Henlius doses first patient in Phase 1 HLX319 Phesgo biosimilar trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2626719827","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626719827?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:51","pubTimestamp":1775811112,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech dosed first subject in mainland China Phase 1 study of HLX319, a subcutaneous biosimilar of Roche’s fixed-dose pertuzumab-trastuzumab product Phesgo.Trial results have not been presented; study is designed to generate comparative evidence to support further development and potential commercialization.Study will compare HLX319 with Phesgo in healthy Chinese male volunteers, focusing on drug exposure, safety, tolerability, and immune response.HLX319 targets HER2-positive breast cancer settings, positioning Henlius to compete in a market where 2025 global sales of subcutaneous pertuzumab-trastuzumab reached USD 3 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL1mMM8q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","00656","HK0000306701.USD","HK0000165453.HKD","HK0000306685.HKD","BK1230","HK0000320264.USD","HK0000320223.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945204","title":"Fosun unit FPI to hold 71.42% voting rights in Sisram after reorganization","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945204","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945204?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:48","pubTimestamp":1775648935,"startTime":"0","endTime":"0","summary":"Fosun Pharma began internal reorganization of its Sisram Medical stake on April 8, 2026, shifting holdings from Ample Up and Chindex to indirect unit Fosun Pharma Industrial.Ample Up will transfer 207,186,160 Sisram shares, equal to 44.2% of issued shares.Chindex will transfer 127,318,640 shares, equal to 27.2%.Completion would leave Fosun Pharma Industrial holding 334,504,800 shares, equal to 71.4% of voting rights.Regulator granted Fosun Pharma waiver from mandatory general offer requirement tied to voting rights increase.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  ,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL4bnYMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01696","BK0012","600196","BK0028","BK0096","BK0175","BK1593","BK0187","BK1230","BK0188","00656","BK1100","BK0196","BK1585","BK0183","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189089844","title":"FOSUN INTL Spends HKD 39.75 Million to Repurchase 9.50 Million Shares; Outstanding Buy-Backs Reach 16.50 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1189089844","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189089844?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:21","pubTimestamp":1775647270,"startTime":"0","endTime":"0","summary":"FOSUN INTL disclosed that on 08 April 2026 it bought back 9.50 million ordinary shares on the Hong Kong Exchange at prices between HKD 4.08 and HKD 4.23, for a total consideration of HKD 39.75...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150964536","title":"FOSUN INTL Buys Back 9.5 Million Shares for HK$39.75 Million on April 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1150964536","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150964536?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:20","pubTimestamp":1775647220,"startTime":"0","endTime":"0","summary":"FOSUN INTL (00656) announced that on April 8, 2026, the company repurchased 9.5 million shares at a total cost of HK$39.75 million. The price per share ranged from HK$4.08 to HK$4.23.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625990174","title":"Assessing Fosun International (SEHK:656) Valuation After 2025 Loss And Shift In Dividend Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2625990174","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625990174?lang=en_us&edition=fundamental","pubTime":"2026-04-08 11:22","pubTimestamp":1775618558,"startTime":"0","endTime":"0","summary":"Fosun International (SEHK:656) has come under closer focus after reporting a larger net loss for 2025, withholding a dividend for the year, and outlining a higher dividend payout framework starting from the 2026 financial year.\nSee our latest analysis for Fosun International.\nThe recent dividend decision and larger 2025 net loss come after a mixed share price pattern, with a 19.5% 1 month share price return and a 9.91% 1 year total shareholder return contrasting with weaker multi year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice2-main-header/1585186874993","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice2-main-header/1585186874993"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/capital-goods/hkg-656/fosun-international-shares/news/assessing-fosun-international-sehk656-valuation-after-2025-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/capital-goods/hkg-656/fosun-international-shares/news/assessing-fosun-international-sehk656-valuation-after-2025-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169567813","title":"FOSUN INTL Reports Record Loss, Chairman Guo Apologizes","url":"https://stock-news.laohu8.com/highlight/detail?id=1169567813","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169567813?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:32","pubTimestamp":1775568750,"startTime":"0","endTime":"0","summary":"FOSUN INTL (00656.HK) released its full-year 2025 financial results on March 30, revealing a stark structural outcome. Impacted by significant non-operating asset impairments, the group recorded its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191465678","title":"FOSUN INTL's Historic Loss: Analyzing the 235 Billion Yuan Deficit and Guo Guangchang's Strategic Missteps","url":"https://stock-news.laohu8.com/highlight/detail?id=1191465678","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191465678?lang=en_us&edition=fundamental","pubTime":"2026-04-04 11:41","pubTimestamp":1775274079,"startTime":"0","endTime":"0","summary":"For nearly two decades, Guo Guangchang has been likened to the \"Chinese Warren Buffett.\" However, this comparison now appears increasingly misplaced, as recent developments suggest a dramatic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125956529","title":"FOSUN INTL Sheds 80 Billion in Assets as Guo Guangchang Accelerates Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=1125956529","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125956529?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:52","pubTimestamp":1775137951,"startTime":"0","endTime":"0","summary":"Guo Guangchang has made a decisive move, undertaking a major cleanup of assets exceeding 700 billion yuan. At the end of March, he wrote a candid open letter to shareholders, stating that, based on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199665698","title":"Fosun Intl issues 26.60 million award shares, lifting outstanding share base by 0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199665698","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199665698?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:24","pubTimestamp":1775125493,"startTime":"0","endTime":"0","summary":"Fosun International Limited disclosed on 02 April 2026 that it has issued a total of 26.60 million new ordinary shares under the share award scheme adopted on 16 March 2023. The allotment comprises...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148173352","title":"FOSUN INTL Issues 26.6 Million Shares Under Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1148173352","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148173352?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:20","pubTimestamp":1775125234,"startTime":"0","endTime":"0","summary":"FOSUN INTL (00656) has announced the issuance and allotment of shares pursuant to its share award scheme. In accordance with the share incentive plan adopted on March 16, 2023, the company issued and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526570","title":"Fosun files HKEX next-day disclosure, issues 26.6 million shares at HKD 0","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526570","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624526570?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:12","pubTimestamp":1775124755,"startTime":"0","endTime":"0","summary":"Fosun International filed next-day disclosure return showing issue of 26.6 million new ordinary shares on April 2, 2026 under its share award scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL9Lb9Mg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195347499","title":"FOSUN INTL Records Massive Loss of 23.4 Billion Yuan; Chairman Apologizes","url":"https://stock-news.laohu8.com/highlight/detail?id=1195347499","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195347499?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:51","pubTimestamp":1775047909,"startTime":"0","endTime":"0","summary":"FOSUN INTL has reported its largest-ever financial loss since its establishment. On March 30, the company released its 2025 performance report, revealing a total annual revenue of 173.43 billion...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fosun.com","stockEarnings":[{"period":"1week","weight":-0.0513},{"period":"1month","weight":0.0252},{"period":"3month","weight":-0.0771},{"period":"6month","weight":-0.2188},{"period":"1year","weight":-0.0005},{"period":"ytd","weight":-0.0708}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.208},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Fosun International Ltd is a company principally engaged in the operation and investments in global consumer business. The Company operates its business through five segments. The Happiness segment engages in the operation and investments in tourism and leisure, fashion consumer and lifestyle industries. The Health segment engages in the research and development, manufacture, sale and trading of pharmaceutical and health products and providing medical services and health management. The Insurance segment mainly engages in the operation of and investment in the insurance businesses. The Asset Management segment comprises principally the operation and investment of asset management, market investments, and investments in other companies of the Group. The Intelligent Manufacturing segment comprises principally the operation of and investment in the intelligent manufacturing and iron, steel, new functional materials and ore production.","yearOnYearQuotes":[{"month":1,"riseRate":0.631579,"avgChangeRate":0.0049},{"month":2,"riseRate":0.473684,"avgChangeRate":0.010096},{"month":3,"riseRate":0.526316,"avgChangeRate":0.003286},{"month":4,"riseRate":0.526316,"avgChangeRate":0.031872},{"month":5,"riseRate":0.555556,"avgChangeRate":0.040571},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.012529},{"month":7,"riseRate":0.388889,"avgChangeRate":0.000713},{"month":8,"riseRate":0.105263,"avgChangeRate":-0.050815},{"month":9,"riseRate":0.578947,"avgChangeRate":-0.012339},{"month":10,"riseRate":0.421053,"avgChangeRate":-0.019588},{"month":11,"riseRate":0.473684,"avgChangeRate":0.019122},{"month":12,"riseRate":0.526316,"avgChangeRate":0.020584}],"exchange":"SEHK","name":"FOSUN INTL","nameEN":"FOSUN INTL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FOSUN INTL(00656),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest FOSUN INTL(00656) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"FOSUN INTL,00656,FOSUN INTL股票,FOSUN INTL股票老虎,FOSUN INTL股票老虎国际,FOSUN INTL行情,FOSUN INTL股票行情,FOSUN INTL股价,FOSUN INTL股市,FOSUN INTL股票价格,FOSUN INTL股票交易,FOSUN INTL股票购买,FOSUN INTL股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FOSUN INTL(00656),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest FOSUN INTL(00656) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}